PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells

  • Jiachi Ma
  • Hirozumi SawaiEmail author
  • Nobuo Ochi
  • Yoichi Matsuo
  • Donghui Xu
  • Akira Yasuda
  • Hiroki Takahashi
  • Takehiro Wakasugi
  • Hiromitsu Takeyama


Phosphoinositide 3-kinase (PI3K) pathway exerts its effects through Akt, its downstream target molecule, and thereby regulates various cell functions including cell proliferation, cell transformation, apoptosis, tumor growth, and angiogenesis. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) has been implicated in regulating cell survival signaling through the PI3K/Akt pathway. However, the mechanism by PI3K/PTEN signaling regulates angiogenesis and tumor growth in vivo remains to be elucidated. Vascular endothelial growth factor (VEGF) plays a pivotal role in tumor angiogenesis. The effect of PTEN on VEGF-mediated signal in pancreatic cancer is unknown. This study aimed to determine the effect of PTEN on both the expression of VEGF and angiogenesis. Toward that end, we used the siRNA knockdown method to specifically define the role of PTEN in the expression of VEGF and angiogenesis. We found that siRNA-mediated inhibition of PTEN gene expression in pancreatic cancer cells increase their VEGF secretion, up-modulated the proliferation, and migration of co-cultured vascular endothelial cell and enhanced tubule formation by HUVEC. In addition, PTEN modulated VEGF-mediated signaling and affected tumor angiogenesis through PI3K/Akt/VEGF/eNOS pathway.


PTEN VEGF Angiogenesis Pancreatic cancer 


  1. 1.
    Tao J, Xiong J, Li T, Yang Z et al (2006) Correlation between protein expression of PTEN in human pancreatic cancer and the proliferation, infiltration, metastasis and prognosis. J Huazhong Univ Sci Technol Med Sci 26:444–447. doi: 10.1007/s11596-006-0417-7 CrossRefPubMedGoogle Scholar
  2. 2.
    Hsu SC, Volpert OV, Steck PA, Mikkelsen T et al (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56:5684–5691PubMedGoogle Scholar
  3. 3.
    Stambolic V, Suzuki A (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39. doi: 10.1016/S0092-8674(00)81780-8 CrossRefPubMedGoogle Scholar
  4. 4.
    Stambolic V, Tsao MS, Macpherson D, Suzuki A et al (2000) High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res 60:3605–3611PubMedGoogle Scholar
  5. 5.
    Liaw D, Marsh DJ, Li J, Dahia PL et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67. doi: 10.1038/ng0597-64 CrossRefPubMedGoogle Scholar
  6. 6.
    Marsh DJ, Dahia PL, Zheng Z, Liaw D et al (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16:333–334. doi: 10.1038/ng0897-333 CrossRefPubMedGoogle Scholar
  7. 7.
    Chow JY, Quach KT, Cabrera BL, Cabral JA et al (2007) RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis 28:2321–2327. doi: 10.1093/carcin/bgm159 CrossRefPubMedGoogle Scholar
  8. 8.
    Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240–4245. doi: 10.1073/pnas.96.8.4240 CrossRefPubMedGoogle Scholar
  9. 9.
    Dong JT, Sipe TW, Hyytinen ER, Li CL, Heise C et al (1998) PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate. Oncogene 17:1979–1982. doi: 10.1038/sj.onc.1202119 CrossRefPubMedGoogle Scholar
  10. 10.
    Simpson L, Parsons R (2001) PTEN: life as a tumor suppressor. Exp Cell Res 264:29–41. doi: 10.1006/excr.2000.5130 CrossRefPubMedGoogle Scholar
  11. 11.
    Alvarez-Nunez F, Bussaglia E, Mauricio D, Ybarra J et al (2006) PTEN promoter methylation in sporadic thyroid carcinomas. Thyroid 16:17–23. doi: 10.1089/thy.2006.16.17 CrossRefPubMedGoogle Scholar
  12. 12.
    Mirmohammadsadegh A, Marini A, Nambiar S, Hassan M et al (2006) Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 66:6546–6552. doi: 10.1158/0008-5472.CAN-06-0384 CrossRefPubMedGoogle Scholar
  13. 13.
    Marsit CJ, Zheng S, Aldape K, Hinds PW et al (2005) PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol 36:768–776. doi: 10.1016/j.humpath.2005.05.006 CrossRefPubMedGoogle Scholar
  14. 14.
    Wiencke JK, Zheng S, Jelluma N, Tihan T et al (2007) Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro-oncology 9:271–279. doi: 10.1215/15228517-2007-003 CrossRefPubMedGoogle Scholar
  15. 15.
    Aoki M, Schetter C, Himly M, Batista O et al (2000) The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity. J Biol Chem 275:6267–6275. doi: 10.1074/jbc.275.9.6267 CrossRefPubMedGoogle Scholar
  16. 16.
    Sakurada A, Suzuki A, Sato M, Yamakawa H et al (1997) Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary. Jpn J Cancer Res 88:1025–1028PubMedGoogle Scholar
  17. 17.
    Escriva M, Peiro S, Herranz N, Villagrasa P, Dave N et al (2008) Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Mol Cell Biol 28:1528–1540. doi: 10.1128/MCB.02061-07 CrossRefPubMedGoogle Scholar
  18. 18.
    Wang Q, Zhou Y, Wang X, Chung DH et al (2007) Regulation of PTEN expression in intestinal epithelial cells by c-Jun NH2-terminal kinase activation and nuclear factor-kappaB inhibition. Cancer Res 67:7773–7781. doi: 10.1158/0008-5472.CAN-07-0187 CrossRefPubMedGoogle Scholar
  19. 19.
    Jiang BH, Zheng JZ, Aoki M et al (2000) Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 97:1749–1753. doi: 10.1073/pnas.040560897 CrossRefPubMedGoogle Scholar
  20. 20.
    Ferrara N (2000) Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55:15–35 (discussion 35–16)PubMedGoogle Scholar
  21. 21.
    Thakker GD, Hajjar DP, Muller WA et al (1999) The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem 274:10002–10007. doi: 10.1074/jbc.274.15.10002 CrossRefPubMedGoogle Scholar
  22. 22.
    Hamada K, Sasaki T, Koni PA, Natsui M et al (2005) The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 19:2054–2065. doi: 10.1101/gad.1308805 CrossRefPubMedGoogle Scholar
  23. 23.
    Giri D, Ittmann M (1999) Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Hum Pathol 30:419–424. doi: 10.1016/S0046-8177(99)90117-X CrossRefPubMedGoogle Scholar
  24. 24.
    Wen S, Stolarov J, Myers MP, Su JD et al (2001) PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci USA 98:4622–4627. doi: 10.1073/pnas.081063798 CrossRefPubMedGoogle Scholar
  25. 25.
    Tahir SA, Yang G, Goltsov AA et al (2008) Tumor cell-secreted caveolin-1 has proangiogenic activity in prostate cancer. Cancer Res 68:731–739. doi: 10.1158/0008-5472.CAN-07-2668 CrossRefPubMedGoogle Scholar
  26. 26.
    Chung BH, Kim CK (2008) Icariin stimulates angiogenesis by activating the MEK/ERK-and PI3K/Akt/eNOS-dependent signal pathway in human endothelial cells. Biochem Biophys Res Commun 376:404–408. doi: 10.1016/j.bbrc.2008.09.001 CrossRefPubMedGoogle Scholar
  27. 27.
    Ferrara N, Chen H, Davis-Smyth T et al (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4:336–340. doi: 10.1038/nm0398-336 CrossRefPubMedGoogle Scholar
  28. 28.
    Ma J, Sawai H, Matsuo Y, Ochi N et al (2008) IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. J Surg Res. doi: 10.1016/j.jss.2008.08.016 Google Scholar
  29. 29.
    Dayanir V, Meyer RD, Lashkari K, Rahimi N (2001) Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biochem 276:17686–17692Google Scholar
  30. 30.
    Lee SJ, Kim NamkoongYM, Kim CK, Lee H et al (2006) Fractalkine stimulates angiogenesis by activating the Raf-/MMK/ERK-and PI3K/Akt/eNOS-dependent signal pathway. Am J Physiol Heart Circ Physiol 291:H2836–H2846. doi: 10.1152/ajpheart.00113.2006 CrossRefPubMedGoogle Scholar
  31. 31.
    Papapetropoulos A, Rudic RD, Sessa WC (1999) Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res 43:509–520. doi: 10.1016/S0008-6363(99)00161-3 CrossRefPubMedGoogle Scholar
  32. 32.
    Dimmeler S, Dernbach E, Zeiher AM (2000) Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477:258–262. doi: 10.1016/S0014-5793(00)01657-4 CrossRefPubMedGoogle Scholar
  33. 33.
    Gomez-Manzano C, Fueyo J, Jiang H, Glass TL et al (2003) Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Ann Neurol 53:109–117. doi: 10.1002/ana.10396 CrossRefPubMedGoogle Scholar
  34. 34.
    Koul D, Shen R, Garyali A, Ke LD et al (2002) MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol 21:469–475PubMedGoogle Scholar
  35. 35.
    Huang J, Kontos CD (2002) PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 277:10760–10766. doi: 10.1074/jbc.M110219200 CrossRefPubMedGoogle Scholar
  36. 36.
    Jiang BH, Liu LZ (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784:150–158PubMedGoogle Scholar
  37. 37.
    Kontos CD, Stauffer TP, Yang WP, York JD et al (1998) Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 18:4131–4140PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Jiachi Ma
    • 1
  • Hirozumi Sawai
    • 1
    Email author
  • Nobuo Ochi
    • 1
  • Yoichi Matsuo
    • 1
  • Donghui Xu
    • 1
  • Akira Yasuda
    • 1
  • Hiroki Takahashi
    • 1
  • Takehiro Wakasugi
    • 1
  • Hiromitsu Takeyama
    • 1
  1. 1.Department of Gastroenterological SurgeryNagoya City University Graduate School of Medical ScienceNagoyaJapan

Personalised recommendations